|
|||||
|
|
Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks |
|
| Authors: | M Bloch WWY Tong J Hoy D Baker FJ Lee R Richardson A Carr TROP study team |
| Affiliation: | 1. Holdsworth House Medical Practice, , Sydney, NSW, Australia;2. St Vincent's Hospital and University of New South Wales, , Sydney, NSW, Australia;3. The Alfred Hospital and Monash University, , Melbourne, Vic., Australia;4. East Sydney Doctors, , Sydney, NSW, Australia |
| Abstract: | |
| Keywords: | bone turnover HIV low bone mineral density raltegravir tenofovir |